Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06015204
Other study ID # 2023-02
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 13, 2023
Est. completion date August 2024

Study information

Verified date September 2023
Source Daegu Catholic University Medical Center
Contact Jonghae Kim, M.D.
Phone +82-10-3360-4885
Email usmed12@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to investigate the effectiveness of photoplethysmographic amplitude in assessing the extent of anesthesia in the 8th cervical dermatome in patients undergoing interscalene brachial plexus block (ISBPB). The main question it aims to answer is - Is there any difference in the post-block changes in photoplethysmographic amplitude measured from the ipsilateral 5th finger (supplied by the 8th cervical nerve root) between ISBPBs targeting the C5-to-C6 nerve roots and the C5-to-C8 nerve roots? - Do the changes in photoplethysmographic amplitude represent the extent of anesthesia in the 8th cervical dermatome? Participants will receive either ISBPB targeting the C5-to-C6 nerve roots or the C5-to-C8 nerve roots, and then the changes in photoplethysmographic amplitude will be measured from the 5th finger ipsilateral to ISBPB.


Recruitment information / eligibility

Status Recruiting
Enrollment 98
Est. completion date August 2024
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria: - American Society of Anesthesiologists physical status 1 or 2 - Schedule to receive interscalene brachial plexus block for arthroscopic shoulder surgery Exclusion Criteria: - Coagulopathy - Peripheral vascular diseases - Arrhythmias - Cardiac conduction abnormalities - A history of medication affecting cardiac conduction - Ischemic heart disease - Hypertension - Diabetes mellitus - Thyroid dysfunction - Other medical conditions affecting autonomic nervous activity - Infection at the skin area for interscalene brachial plexus block - Peripheral neuropathy or neurologic sequelae in the upper limb ipsilateral to the surgery - Allergy to local anesthetics or a history of allergic shock - Contralateral vocal cord palsy, hemidiaphragmatic paresis/paralysis or pneumo/hemo thorax - Severe restrictive pulmonary disorder - Electrolyte imbalance - Difficulty in communicating with medical personnel - Patients refusal

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Interscalene brachial plexus block targeting the C5-to-C6 nerve roots
With the head rotated contralateral to interscalene brachial plexus block (ISBPB), the compactly arranged brachial plexus is visualized lateral to the pulsating subclavian artery under ultrasound guidance. The linear ultrasound transducer is moved cephalad until the C5-to-C8 nerve roots are visualized between the anterior and middle scalene muscles. A block needle is introduced from lateral to medial direction. A nerve root is blocked by placing at least 5 ml of 0.75% ropivacaine around it. The most caudal cervical nerve root (C6 nerve root) is blocked first, and the most cephalad one (C5 nerve root) is blocked last. Then, 3 ml of 0.75% ropivacaine is placed between the scalene and sternocleidomastoid muscles to block the supraclavicular nerves. An equivalent volume of a standard study drug is planned to be used (A total of 25 ml of 0.75% ropivacaine).
Interscalene brachial plexus block targeting the C5-to-C8 nerve roots
With the head rotated contralateral to interscalene brachial plexus block (ISBPB), the compactly arranged brachial plexus is visualized lateral to the pulsating subclavian artery under ultrasound guidance. The linear ultrasound transducer is moved cephalad until the C5-to-C8 nerve roots are visualized between the anterior and middle scalene muscles. A block needle is introduced from lateral to medial direction. A nerve root is blocked by placing at least 5 ml of 0.75% ropivacaine around it. The most caudal cervical nerve root (C8 nerve root) is blocked first, and the most cephalad one (C5 nerve root) is blocked last. Then, 3 ml of 0.75% ropivacaine is placed between the scalene and sternocleidomastoid muscles to block the supraclavicular nerves. An equivalent volume of a standard study drug is planned to be used (A total of 25 ml of 0.75% ropivacaine).

Locations

Country Name City State
Korea, Republic of Daegu Catholic University Medical Center Daegu

Sponsors (2)

Lead Sponsor Collaborator
JongHae Kim Research Institute of Medical Science, Daegu Catholic University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Other Complications related to interscalene brachial plexus block Accidental puncture of the common carotid, subclavian, or vertebral artery, pneumo/hemothorax, epidural or intrathecal injection of local anesthetic, local anesthetic systemic toxicity, and other neurological complications 35 minutes after the introduction of a block needle
Other Baseline systolic blood pressure Measured with a non-invasive blood pressure cuff 5 minutes before the introduction of a block needle
Other Post-block systolic blood pressure Measured with a non-invasive blood pressure cuff 35 minutes after the introduction of a block needle
Other Baseline heart rate Measured from electrocardiogram 5 minutes before the introduction of a block needle
Other Post-block heart rate Measured from electrocardiogram 35 minutes after the introduction of a block needle
Primary Time to achieve 50% of maximum photoplethysmographic amplitude measured from the 5th finger During the whole study period, the photoplethysmographic waveform obtained from the 1st and 5th fingers ipsilateral to interscalene brachial plexus block is recorded at 100 Hz. The photoplethysmographic amplitude is calculated by subtracting the valley amplitude from the peak amplitude of one heartbeat in photoplethysmographic waveform. Using all the photoplethysmographic amplitudes between 0 and 25 minutes after the introduction of a block needle, a sigmoid Emax model is built. From the model, the time point, when 50% of maximum photoplethysmographic amplitude is achieved, can be derived. 25 minutes after the introduction of a block needle
Secondary Time to achieve 5% of maximum photoplethysmographic amplitude measured from the 5th finger During the whole study period, the photoplethysmographic waveform obtained from the 1st and 5th fingers ipsilateral to interscalene brachial plexus block is recorded at 100 Hz. The photoplethysmographic amplitude is calculated by subtracting the valley amplitude from the peak amplitude of one heartbeat in photoplethysmographic waveform. Using all the photoplethysmographic amplitudes between 0 and 25 minutes after the introduction of a block needle, a sigmoid Emax model is built. From the model, the time point, when 5% of maximum photoplethysmographic amplitude is achieved, can be derived. 25 minutes after the introduction of a block needle
Secondary Time to achieve 10% of maximum photoplethysmographic amplitude measured from the 5th finger During the whole study period, the photoplethysmographic waveform obtained from the 1st and 5th fingers ipsilateral to interscalene brachial plexus block is recorded at 100 Hz. The photoplethysmographic amplitude is calculated by subtracting the valley amplitude from the peak amplitude of one heartbeat in photoplethysmographic waveform. Using all the photoplethysmographic amplitudes between 0 and 25 minutes after the introduction of a block needle, a sigmoid Emax model is built. From the model, the time point, when 10% of maximum photoplethysmographic amplitude is achieved, can be derived. 25 minutes after the introduction of a block needle
Secondary Time to achieve 90% of maximum photoplethysmographic amplitude measured from the 5th finger During the whole study period, the photoplethysmographic waveform obtained from the 1st and 5th fingers ipsilateral to interscalene brachial plexus block is recorded at 100 Hz. The photoplethysmographic amplitude is calculated by subtracting the valley amplitude from the peak amplitude of one heartbeat in photoplethysmographic waveform. Using all the photoplethysmographic amplitudes between 0 and 25 minutes after the introduction of a block needle, a sigmoid Emax model is built. From the model, the time point, when 90% of maximum photoplethysmographic amplitude is achieved, can be derived. 25 minutes after the introduction of a block needle
Secondary Time to achieve 95% of maximum photoplethysmographic amplitude measured from the 5th finger During the whole study period, the photoplethysmographic waveform obtained from the 1st and 5th fingers ipsilateral to interscalene brachial plexus block is recorded at 100 Hz. The photoplethysmographic amplitude is calculated by subtracting the valley amplitude from the peak amplitude of one heartbeat in photoplethysmographic waveform. Using all the photoplethysmographic amplitudes between 0 and 25 minutes after the introduction of a block needle, a sigmoid Emax model is built. From the model, the time point, when 95% of maximum photoplethysmographic amplitude is achieved, can be derived. 25 minutes after the introduction of a block needle
Secondary Time to achieve 99% of maximum photoplethysmographic amplitude measured from the 5th finger During the whole study period, the photoplethysmographic waveform obtained from the 1st and 5th fingers ipsilateral to interscalene brachial plexus block is recorded at 100 Hz. The photoplethysmographic amplitude is calculated by subtracting the valley amplitude from the peak amplitude of one heartbeat in photoplethysmographic waveform. Using all the photoplethysmographic amplitudes between 0 and 25 minutes after the introduction of a block needle, a sigmoid Emax model is built. From the model, the time point, when 99% of maximum photoplethysmographic amplitude is achieved, can be derived. 25 minutes after the introduction of a block needle
Secondary Time to achieve 5% of maximum photoplethysmographic amplitude measured from the 1st finger During the whole study period, the photoplethysmographic waveform obtained from the 1st and 5th fingers ipsilateral to interscalene brachial plexus block is recorded at 100 Hz. The photoplethysmographic amplitude is calculated by subtracting the valley amplitude from the peak amplitude of one heartbeat in photoplethysmographic waveform. Using all the photoplethysmographic amplitudes between 0 and 25 minutes after the introduction of a block needle, a sigmoid Emax model is built. From the model, the time point, when 5% of maximum photoplethysmographic amplitude is achieved, can be derived. 25 minutes after the introduction of a block needle
Secondary Time to achieve 10% of maximum photoplethysmographic amplitude measured from the 1st finger During the whole study period, the photoplethysmographic waveform obtained from the 1st and 5th fingers ipsilateral to interscalene brachial plexus block is recorded at 100 Hz. The photoplethysmographic amplitude is calculated by subtracting the valley amplitude from the peak amplitude of one heartbeat in photoplethysmographic waveform. Using all the photoplethysmographic amplitudes between 0 and 25 minutes after the introduction of a block needle, a sigmoid Emax model is built. From the model, the time point, when 10% of maximum photoplethysmographic amplitude is achieved, can be derived. 25 minutes after the introduction of a block needle
Secondary Time to achieve 50% of maximum photoplethysmographic amplitude measured from the 1st finger During the whole study period, the photoplethysmographic waveform obtained from the 1st and 5th fingers ipsilateral to interscalene brachial plexus block is recorded at 100 Hz. The photoplethysmographic amplitude is calculated by subtracting the valley amplitude from the peak amplitude of one heartbeat in photoplethysmographic waveform. Using all the photoplethysmographic amplitudes between 0 and 25 minutes after the introduction of a block needle, a sigmoid Emax model is built. From the model, the time point, when 50% of maximum photoplethysmographic amplitude is achieved, can be derived. 25 minutes after the introduction of a block needle
Secondary Time to achieve 90% of maximum photoplethysmographic amplitude measured from the 1st finger During the whole study period, the photoplethysmographic waveform obtained from the 1st and 5th fingers ipsilateral to interscalene brachial plexus block is recorded at 100 Hz. The photoplethysmographic amplitude is calculated by subtracting the valley amplitude from the peak amplitude of one heartbeat in photoplethysmographic waveform. Using all the photoplethysmographic amplitudes between 0 and 25 minutes after the introduction of a block needle, a sigmoid Emax model is built. From the model, the time point, when 90% of maximum photoplethysmographic amplitude is achieved, can be derived. 25 minutes after the introduction of a block needle
Secondary Time to achieve 95% of maximum photoplethysmographic amplitude measured from the 1st finger During the whole study period, the photoplethysmographic waveform obtained from the 1st and 5th fingers ipsilateral to interscalene brachial plexus block is recorded at 100 Hz. The photoplethysmographic amplitude is calculated by subtracting the valley amplitude from the peak amplitude of one heartbeat in photoplethysmographic waveform. Using all the photoplethysmographic amplitudes between 0 and 25 minutes after the introduction of a block needle, a sigmoid Emax model is built. From the model, the time point, when 95% of maximum photoplethysmographic amplitude is achieved, can be derived. 25 minutes after the introduction of a block needle
Secondary Time to achieve 99% of maximum photoplethysmographic amplitude measured from the 1st finger During the whole study period, the photoplethysmographic waveform obtained from the 1st and 5th fingers ipsilateral to interscalene brachial plexus block is recorded at 100 Hz. The photoplethysmographic amplitude is calculated by subtracting the valley amplitude from the peak amplitude of one heartbeat in photoplethysmographic waveform. Using all the photoplethysmographic amplitudes between 0 and 25 minutes after the introduction of a block needle, a sigmoid Emax model is built. From the model, the time point, when 99% of maximum photoplethysmographic amplitude is achieved, can be derived. 25 minutes after the introduction of a block needle
Secondary Baseline blood flow measured from the brachial artery ipsilateral to interscalene brachial plexus block The linear ultrasound transducer is placed parallel with the brachial artery at the antecubital fossa. Using pulse wave Doppler ultrasound, time velocity integral per heartbeat is calculated. The cross-sectional diameter of the artery is measured with the transducer placed transversely to the artery. The blood flow of the artery (ml/min) is the product of the averaged time velocity integral (cm), cross-sectional area of the artery (cm2), and heart rate (beats/min). 15 minutes before the introduction of a block needle
Secondary Baseline blood flow measured from the radial artery ipsilateral to interscalene brachial plexus block The linear ultrasound transducer is placed parallel with the radial artery at the distal forearm area. Using pulse wave Doppler ultrasound, time velocity integral per heartbeat is calculated. The cross-sectional diameter of the artery is measured with the transducer placed transversely to the artery. The blood flow of the artery (ml/min) is the product of the averaged time velocity integral (cm), cross-sectional area of the artery (cm2), and heart rate (beats/min). 15 minutes before the introduction of a block needle
Secondary Baseline blood flow measured from the ulnar artery ipsilateral to interscalene brachial plexus block The linear ultrasound transducer is placed parallel with the ulnar artery at the distal forearm area. Using pulse wave Doppler ultrasound, time velocity integral per heartbeat is calculated. The cross-sectional diameter of the artery is measured with the transducer placed transversely to the artery. The blood flow of the artery (ml/min) is the product of the averaged time velocity integral (cm), cross-sectional area of the artery (cm2), and heart rate (beats/min). 15 minutes before the introduction of a block needle
Secondary Post-block blood flow measured from the brachial artery ipsilateral to interscalene brachial plexus block The linear ultrasound transducer is placed parallel with the brachial artery at the antecubital fossa. Using pulse wave Doppler ultrasound, time velocity integral per heartbeat is calculated. The cross-sectional diameter of the artery is measured with the transducer placed transversely to the artery. The blood flow of the artery (ml/min) is the product of the averaged time velocity integral (cm), cross-sectional area of the artery (cm2), and heart rate (beats/min). 25 minutes after the introduction of a block needle
Secondary Post-block blood flow measured from the radial artery ipsilateral to interscalene brachial plexus block The linear ultrasound transducer is placed parallel with the radial artery at the distal forearm area. Using pulse wave Doppler ultrasound, time velocity integral per heartbeat is calculated. The cross-sectional diameter of the artery is measured with the transducer placed transversely to the artery. The blood flow of the artery (ml/min) is the product of the averaged time velocity integral (cm), cross-sectional area of the artery (cm2), and heart rate (beats/min). 25 minutes after the introduction of a block needle
Secondary Post-block blood flow measured from the ulnar artery ipsilateral to interscalene brachial plexus block The linear ultrasound transducer is placed parallel with the ulnar artery at the distal forearm area. Using pulse wave Doppler ultrasound, time velocity integral per heartbeat is calculated. The cross-sectional diameter of the artery is measured with the transducer placed transversely to the artery. The blood flow of the artery (ml/min) is the product of the averaged time velocity integral (cm), cross-sectional area of the artery (cm2), and heart rate (beats/min). 25 minutes after the introduction of a block needle
Secondary Sensory blockade of the C5 dermatome Using an alcohol swab, the sensory blockade of each dermatome is graded as 0 (no cold sensation), 1 (reduced cold sensation), 2 (normal cold sensation). 30 minutes after the introduction of a block needle
Secondary Sensory blockade of the C6 dermatome Using an alcohol swab, the sensory blockade of each dermatome is graded as 0 (no cold sensation), 1 (reduced cold sensation), 2 (normal cold sensation). 30 minutes after the introduction of a block needle
Secondary Sensory blockade of the C7 dermatome Using an alcohol swab, the sensory blockade of each dermatome is graded as 0 (no cold sensation), 1 (reduced cold sensation), 2 (normal cold sensation). 30 minutes after the introduction of a block needle
Secondary Sensory blockade of the C8 dermatome Using an alcohol swab, the sensory blockade of each dermatome is graded as 0 (no cold sensation), 1 (reduced cold sensation), 2 (normal cold sensation). 30 minutes after the introduction of a block needle
Secondary Sensory blockade of the T1 dermatome Using an alcohol swab, the sensory blockade of each dermatome is graded as 0 (no cold sensation), 1 (reduced cold sensation), 2 (normal cold sensation). 30 minutes after the introduction of a block needle
Secondary Motor blockade of shoulder abduction Motor blockade is assessed by rating the force of movement corresponding to each nerve as 0 (complete block), 1 (partial block), or 2 (no block). 30 minutes after the introduction of a block needle
Secondary Motor blockade of elbow flexion Motor blockade is assessed by rating the force of movement corresponding to each nerve as 0 (complete block), 1 (partial block), or 2 (no block). 30 minutes after the introduction of a block needle
Secondary Motor blockade of forearm supination Motor blockade is assessed by rating the force of movement corresponding to each nerve as 0 (complete block), 1 (partial block), or 2 (no block). 30 minutes after the introduction of a block needle
Secondary Motor blockade of forearm pronation Motor blockade is assessed by rating the force of movement corresponding to each nerve as 0 (complete block), 1 (partial block), or 2 (no block). 30 minutes after the introduction of a block needle
Secondary Motor blockade of finger abduction Motor blockade is assessed by rating the force of movement corresponding to each nerve as 0 (complete block), 1 (partial block), or 2 (no block). 30 minutes after the introduction of a block needle
Secondary Motor blockade of thumb abduction Motor blockade is assessed by rating the force of movement corresponding to each nerve as 0 (complete block), 1 (partial block), or 2 (no block). 30 minutes after the introduction of a block needle
Secondary Motor blockade of thumb adduction Motor blockade is assessed by rating the force of movement corresponding to each nerve as 0 (complete block), 1 (partial block), or 2 (no block). 30 minutes after the introduction of a block needle
Secondary Motor blockade of thumb opposition Motor blockade is assessed by rating the force of movement corresponding to each nerve as 0 (complete block), 1 (partial block), or 2 (no block). 30 minutes after the introduction of a block needle
Secondary Baseline pupil diameter ipsilateral to interscalene brachial plexus block Three minutes after the adaptation in low mesopic conditions, the pupil diameter is measured for 2 seconds at 30 Hz using a portable pupillometer. The pupil diameter is obtained by averaging 60 measurement values. 5 minutes before the introduction of a block needle
Secondary Baseline pupil diameter contralateral to interscalene brachial plexus block Three minutes after the adaptation in low mesopic conditions, the pupil diameter is measured for 2 seconds at 30 Hz using a portable pupillometer. The pupil diameter is obtained by averaging 60 measurement values. 5 minutes before the introduction of a block needle
Secondary Post-block pupil diameter ipsilateral to interscalene brachial plexus block Three minutes after the adaptation in low mesopic conditions, the pupil diameter is measured for 2 seconds at 30 Hz using a portable pupillometer. The pupil diameter is obtained by averaging 60 measurement values. 35 minutes after the introduction of a block needle
Secondary Post-block pupil diameter contralateral to interscalene brachial plexus block Three minutes after the adaptation in low mesopic conditions, the pupil diameter is measured for 2 seconds at 30 Hz using a portable pupillometer. The pupil diameter is obtained by averaging 60 measurement values. 35 minutes after the introduction of a block needle
Secondary Pain upon a pinch at the skin area for posterior portal placement (1.5-3 cm inferior and medial to the posterolateral tip of the acromion) The pain intensity is rated as 0 (no pain), 1 (mild pain), and 2 (severe pain). 1 minute before the surgical incision
Secondary Pain upon surgical incision (1.5-3 cm inferior and medial to the posterolateral tip of the acromion) The pain intensity is rated as 0 (no pain), 1 (mild pain), and 2 (severe pain). An average of 1 hour after the introduction of a block needle
Secondary Pain upon posterior portal placement (1.5-3 cm inferior and medial to the posterolateral tip of the acromion) The pain intensity is rated as 0 (no pain), 1 (mild pain), and 2 (severe pain). 1 minute after surgical incision
See also
  Status Clinical Trial Phase
Withdrawn NCT04053491 - Comparison of the Infraclavicular and Axillary Approaches for Continuous Ultrasound-guided Brachial Plexus Block. N/A
Completed NCT03211949 - Ultrasound Guided Topographic Mapping of Medial Antebrachial Cutaneous Nerve N/A
Suspended NCT03291691 - Protective Nerve Stimulation in Regional Anesthesia
Completed NCT03270033 - Intravenous Dexmedetomidine, Dexamethasone and Interscalene Block Duration After Arthroscopic Shoulder Surgery Phase 4
Not yet recruiting NCT03279679 - Comparison Between Costoclavicular and Paracoracoid Ultrasound-guided Infraclavicular Block for Forearm Surgery N/A
Completed NCT02305875 - The Musculocutaneous Nerve in a High Resolution MRI N/A
Completed NCT03688724 - Perioperative Diaphragm Point of Care Ultrasound
Completed NCT05005260 - Liposomal Bupivacaine Single-Injection Interscalene Block vs. Continuous Interscalene Block for Primary Total Shoulder Arthroplasty Phase 4
Completed NCT02462408 - Conventional Versus Posterior Approach in Ultrasound-Guided Parasagittal In-Plane Infraclavicular Brachial Plexus Block N/A
Completed NCT02312453 - Posterior Parasagittal In-Plane Ultrasound-Guided Infraclavicular Brachial Plexus Block N/A
Completed NCT00321425 - Ultrasound Guidance Vs. Electrical Nerve Stimulation for Infraclavicular Brachial Plexus Block N/A
Recruiting NCT03577860 - Ventilation and Pulmonary Aeration, Electrical Impedance Tomography, Interscalene Brachial Plexus Block N/A
Completed NCT04356521 - Lateral Sagittal vs Costoclavicular Approach for Ultrasound-Guided Infraclavicular Block N/A
Completed NCT04463329 - Jedi Grip vs. Double Operator Technique for Axillary Brachial Plexus Block N/A
Not yet recruiting NCT04784104 - Comparison of Infraclavicular And Supraclavicular Block Phase 4
Terminated NCT03785392 - Out of Plane Approach for Interscalene N/A
Completed NCT02787018 - Dexamethasone Compared With Dexmedetomidine as an Adjuvant to Ropivacaine for Supraclavicular Brachial Plexus Block Phase 3
Completed NCT03514342 - The Effects of Horner's Syndrome Developing After Interscalene Brachial Plexus Block on Autonomic Nervous Activity
Completed NCT05315271 - Supraclavicular Brachial Plexus Block During Upper Limb Surgeries Early Phase 1
Completed NCT04694105 - Peri-neural Dexmedetomidine Versus Dexamethasone for Supraaclavicular Block Adjuvant to Bupivacaine Supraclavicular Brachial Plexus Block N/A